David Einhorn’s hedge fund Greenlight Capital picked up a new stake in Kenvue Inc. KVUE — formerly the consumer healthcare division of Johnson & Johnson JNJ — in the fourth quarter, according to a public filing Wednesday.
Greenlight acquired about a $12 million stake in Kenvue in the fourth quarter, while also adding a nearly $2.7 million exposure to Israeli generic-drug giant Teva Pharmaceutical Industries Ltd. TEVA, according to a 13F quarterly filing with the U.S. Securities and Exchange Commission.
The…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Subscribe Now
Already a subscriber?
Log In
Read the full article here
